Bildkälla: Stockfoto

Pila Pharma: Tox-studies initiated - Redeye

Redeye leaves its comments on Pila Pharma following today’s uplifting news that the three-month preclinical toxicological studies have been initiated.

Redeye leaves its comments on Pila Pharma following today’s uplifting news that the three-month preclinical toxicological studies have been initiated.
Börsvärldens nyhetsbrev
ANNONSER